112 related articles for article (PubMed ID: 1458765)
1. Lack of pharmacokinetic interactions between moxonidine and digoxin.
Pabst G; Weimann HJ; Weber W
Clin Pharmacokinet; 1992 Dec; 23(6):477-81. PubMed ID: 1458765
[TBL] [Abstract][Full Text] [Related]
2. Steady state investigation of possible pharmacokinetic interactions of moxonidine and glibenclamide.
Müller M; Weimann HJ; Eden G; Weber W; Michaelis K; Dilger C; Achtert G
Eur J Drug Metab Pharmacokinet; 1993; 18(3):277-83. PubMed ID: 8149947
[TBL] [Abstract][Full Text] [Related]
3. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G
Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers.
Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK
Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction of sparfloxacin and digoxin.
Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
Harder S; Thürmann PA
Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
[TBL] [Abstract][Full Text] [Related]
7. Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.
Smulders RA; Kuipers ME; Krauwinkel WJ
Br J Clin Pharmacol; 2006 Aug; 62(2):210-7. PubMed ID: 16842396
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.
Khoo KC; Givens SV; Parsonnet M; Massarella JW
J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of moxonidine after single and repeated daily doses in healthy volunteers.
Trenk D; Wagner F; Jähnchen E; Plänitz V
J Clin Pharmacol; 1987 Dec; 27(12):988-93. PubMed ID: 3437071
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin.
Kovarik JM; Rigaudy L; Guerret M; Gerbeau C; Rost KL
Clin Pharmacol Ther; 1999 Oct; 66(4):391-400. PubMed ID: 10546923
[TBL] [Abstract][Full Text] [Related]
11. Quinidine does not affect the renal clearance of moxonidine.
Wise SD; Chan C; Schaefer HG; He MM; Pouliquen IJ; Mitchell MI
Br J Clin Pharmacol; 2002 Sep; 54(3):251-4. PubMed ID: 12236844
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term oral carvedilol on the steady-state pharmacokinetics of oral digoxin in patients with mild to moderate hypertension.
Wermeling DP; Field CJ; Smith DA; Chandler MH; Clifton GD; Boyle DA
Pharmacotherapy; 1994; 14(5):600-6. PubMed ID: 7997394
[TBL] [Abstract][Full Text] [Related]
13. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
[TBL] [Abstract][Full Text] [Related]
14. Digoxin pharmacokinetics and spirapril, a new ace inhibitor.
Johnson BF; Wilson J; Johnson J; Flemming J
J Clin Pharmacol; 1991 Jun; 31(6):527-30. PubMed ID: 1880218
[TBL] [Abstract][Full Text] [Related]
15. No effect of imidafenacin, a novel antimuscarinic drug, on digoxin pharmacokinetics in healthy subjects.
Nakade S; Ohno T; Nakayama K; Kitagawa J; Hashimoto Y; Ohnishi A; Miyata Y
Drug Metab Pharmacokinet; 2008; 23(2):95-100. PubMed ID: 18445988
[TBL] [Abstract][Full Text] [Related]
16. Influence of food on the oral bioavailability of moxonidine.
Theodor RA; Weimann HJ; Weber W; Müller M; Michaelis K
Eur J Drug Metab Pharmacokinet; 1992; 17(1):61-6. PubMed ID: 1499598
[TBL] [Abstract][Full Text] [Related]
17. Absence of an interaction between tigecycline and digoxin in healthy men.
Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
[TBL] [Abstract][Full Text] [Related]
18. Effects of concurrent administration of flosequinan and digoxin on the pharmacokinetics of each drug.
Rau R; Hind ID; Wynne RD; White SA
Arzneimittelforschung; 1994 Mar; 44(3):300-4. PubMed ID: 8192694
[TBL] [Abstract][Full Text] [Related]
19. Absence of pharmacokinetic interaction between roflumilast and digoxin in healthy adults.
Eckermann G; Lahu G; Nassr N; Bethke TD
J Clin Pharmacol; 2012 Feb; 52(2):251-7. PubMed ID: 21257799
[TBL] [Abstract][Full Text] [Related]
20. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
Shoaf SE; Ohzone Y; Ninomiya S; Furukawa M; Bricmont P; Kashiyama E; Mallikaarjun S
J Clin Pharmacol; 2011 May; 51(5):761-9. PubMed ID: 20679500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
